ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WBA Walgreens Boots Alliance Inc

17.75
0.15 (0.85%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Walgreens Boots Alliance Inc NASDAQ:WBA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 0.85% 17.75 17.71 17.74 17.95 17.49 17.50 6,591,864 00:56:56

Walgreens Swings to Loss as Pandemic Weighs on Customer Visits

09/07/2020 1:17pm

Dow Jones News


Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Walgreens Boots Alliance Charts.
By Micah Maidenberg 

Walgreens Boots Alliance Inc. said demand fell off in its international business during the drugstore chain's latest quarter as consumers in the U.K. stayed at home amid the coronavirus pandemic, hurting its business in that market.

The pharmacy chain on Thursday said the Covid-19 pandemic sliced out around $700 million to $750 million in sales for its quarter that ended May 31, with most of the impact tied to its retail pharmacy business overseas.

A "dramatic reduction" in customer traffic, including an 85% decline in April, weighed on demand for its Boots U.K. stores, Walgreens said. The company said it recorded noncash impairment charges of $2 billion tied to the Boots U.K. unit.

Overall, Walgreens said it lost $1.71 billion, or $1.95 a share, for its latest quarter, compared with a year-earlier profit of $1.03 billion, or $1.13 a share. Its adjusted profit fell to 83 cents a share and was short of expectations.

The company generated $34.6 billion in sales, roughly flat year over year. Analysts polled by FactSet predicted $34.3 billion in sales for the latest period.

In the U.S. retail unit, sales rose about 3% from a year earlier to $27.4 billion for the latest quarter. Pharmacy sales were up 4.6%, while prescriptions filled in the third quarter decreased 1.3%.

The Covid-19 pandemic has been challenging for drugstores, as patients put off visiting doctors and other health providers. Walgreens is part of a coalition of health-focused companies that is paying for advertisements that encourage people to return to their medical providers.

"Globally, pharmacy volume was impacted by a drop in doctor visits and hospital patient admissions," the company said.

Walgreens is working with and investing in primary-care provider VillageMD to open 500 to 700 doctors' offices in its drugstores.

Rival CVS Health Corp. is developing so-called health-care hubs in its stores, offering a range of medical services. Walmart Inc. is also adding clinics to its locations.

Write to Micah Maidenberg at micah.maidenberg@wsj.com

 

(END) Dow Jones Newswires

July 09, 2020 08:02 ET (12:02 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Walgreens Boots Alliance Chart

1 Year Walgreens Boots Alliance Chart

1 Month Walgreens Boots Alliance Chart

1 Month Walgreens Boots Alliance Chart

Your Recent History

Delayed Upgrade Clock